This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Zenonas Danilevicius, MD

JAMA. 1977;237(21):2326.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Elliott et al¹ were probably the first to indicate that prostaglandin E₁ infused into infants enlarged the patency of ductus arteriosus. Their findings also suggested that administration of a nonspecific antagonist of prostaglandin synthesis, such as indomethacin, was associated with a fall in arterial saturation.

Cotton et al² showed that medical management of symptomatic ductus arteriosus shunts in small preterm infants is possible. They used digitalis, mechanical ventilation, and transfusions. Although the results of medical management indicated the effectiveness of conservative means, Cotton considered that surgical treatment may be unavoidable in life-threatening situations.

Pharmacologic closure of patent ductus arteriosus using indomethacin was achieved by Friedman et al.³ Within 24 hours, all the clinical symptoms and signs attributable to left-to-right shunting dramatically and permanently disappeared in infants receiving the drug.

Heymann et al⁴ reported their experience with 18 infants who had cardiac failure associated with persistent . . . [Full Text PDF of this Article]

Footnotes
Address editorial communications to the Editor, 535 N Dearborn St, Chicago 60610

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?